10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      RNF126‐Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple‐Negative Breast Cancer to Radiotherapy

      research-article
      1 , 2 , 3 , 1 , 2 , 1 , 1 , 2 , 1 , 2 , 4 , 1 , 2 , 5 , 1 , 2 , 1 , 6 , 3 , 7 , 3 , 7 , 1 , 1 , 8 , 9 , 9 , 10 , 11 , , 1 , 2 , , 1 , 5 , 3 ,
      Advanced Science
      John Wiley and Sons Inc.
      ataxia telangiectasia mutated and rad‐3 related protein kinase (ATR), dihydroartemisinin, homologous recombination repair, human epidermal growth factor receptor 2 (HER2), Meiotic recombination 11 homolog 1 (MRE11), Nuclear Factor Kappa‐Β (NF‐κB), Ring finger protein 126 (RNF126)

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Triple‐negative breast cancer (TNBC) has higher molecular heterogeneity and metastatic potential and the poorest prognosis. Because of limited therapeutics against TNBC, irradiation (IR) therapy is still a common treatment option for patients with lymph nodes or brain metastasis. Thus, it is urgent to develop strategies to enhance the sensitivity of TNBC tumors to low‐dose IR. Here, the authors report that E3 ubiquitin ligase Ring finger protein 126 (RNF126) is important for IR‐induced ATR‐CHK1 pathway activation to enhance DNA damage repair (DDR). Mechanistically, RNF126 physically associates with the MRE11‐RAD50‐NBS1 (MRN) complex and ubiquitinates MRE11 at K339 and K480 to increase its DNA exonuclease activity, subsequent RPA binding, and ATR phosphorylation, promoting sustained DDR in a homologous recombination repair‐prone manner. Accordingly, depletion of RNF126 leads to increased genomic instability and radiation sensitivity in both TNBC cells and mice. Furthermore, it is found that RNF126 expression is induced by IR activating the HER2‐AKT‐NF‐ κB pathway and targeting RNF126 expression with dihydroartemisinin significantly improves the sensitivity of TNBC tumors in the brain to IR treatment in vivo. Together, these results reveal that RNF126‐mediated MRE11 ubiquitination is a critical regulator of the DDR, which provides a promising target for improving the sensitivity of TNBC to radiotherapy.

          Abstract

          RNF126 is first reported to mediate the non‐degradative ubiquitination of MRE11 to facilitate its exonuclease activity and promote homologous recombination repair, which is induced by the IR‐activating HER2‐AKT‐NF‐ κB pathway in TNBC cells. Dihydroartemisinin, a potent antimalarial agent, is proven to inhibit RNF126 expression and enhance radiotherapy sensitization on mouse model with a TNBC tumor in the brain, exhibiting high potential in clinical application.

          Related collections

          Author and article information

          Contributors
          1363175515@bjmu.edu.cn
          jiangdewei@mail.kiz.ac.cn
          chenc@mail.kiz.ac.cn
          Journal
          Adv Sci (Weinh)
          Adv Sci (Weinh)
          10.1002/(ISSN)2198-3844
          ADVS
          Advanced Science
          John Wiley and Sons Inc. (Hoboken )
          2198-3844
          23 December 2022
          February 2023
          : 10
          : 5 ( doiID: 10.1002/advs.v10.5 )
          : 2203884
          Affiliations
          [ 1 ] Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province Kunming Institute of Zoology Chinese Academy of Sciences Kunming 650201 China
          [ 2 ] Kunming College of Life Sciences University of the Chinese Academy of Sciences Kunming 650204 China
          [ 3 ] The Third Affiliated Hospital Kunming Medical University Kunming 650118 China
          [ 4 ] Department of the Pathology First Affiliated Hospital of Kunming Medical University Kunming 650032 China
          [ 5 ] Academy of Biomedical Engineering Kunming Medical University Kunming 650500 China
          [ 6 ] School of Life Science University of Science & Technology of China Hefei 230027 China
          [ 7 ] Department of Biochemistry and Molecular Biology Tianjin Medical University Tianjin 300070 China
          [ 8 ] Translational Cancer Research Center Peking University First Hospital Beijing 100034 China
          [ 9 ] Department of the Central Laboratory Second Affiliated Hospital of Kunming Medical University Kunming 650032 China
          [ 10 ] Department of Pathology the Second Xiangya Hospital Central South University Changsha 410000 China
          [ 11 ] Center for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing 100191 China
          Author notes
          Author information
          https://orcid.org/0000-0003-1177-0599
          https://orcid.org/0000-0002-7773-5449
          https://orcid.org/0000-0001-6398-3516
          Article
          ADVS4962
          10.1002/advs.202203884
          9929257
          36563124
          eb572b09-7caa-4b91-b5ef-eb0a217e3cd1
          © 2022 The Authors. Advanced Science published by Wiley‐VCH GmbH

          This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

          History
          : 05 December 2022
          : 06 July 2022
          Page count
          Figures: 8, Tables: 0, Pages: 16, Words: 10639
          Funding
          Funded by: National Key R&D Program of China
          Award ID: 2020YFA0112300
          Award ID: 2020YFA0803200
          Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
          Award ID: 81830087
          Award ID: U2102203
          Award ID: 82173014
          Award ID: 81872414
          Award ID: 81971440
          Funded by: CAS Light of West China program
          Award ID: 2021000006
          Funded by: Beijing Natural Science Foundation , doi 10.13039/501100004826;
          Award ID: 7212129
          Categories
          Research Article
          Research Articles
          Custom metadata
          2.0
          February 14, 2023
          Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.5 mode:remove_FC converted:15.02.2023

          ataxia telangiectasia mutated and rad‐3 related protein kinase (atr),dihydroartemisinin,homologous recombination repair,human epidermal growth factor receptor 2 (her2),meiotic recombination 11 homolog 1 (mre11),nuclear factor kappa‐β (nf‐κb),ring finger protein 126 (rnf126)

          Comments

          Comment on this article